GroundRules
Browse Federal regulations
Read the original sections, or search by topic.
- 21 CFR 520.812 · Enrofloxacin.
- 21 CFR 520.816 · Epsiprantel.
- 21 CFR 520.823 · Erythromycin.
- 21 CFR 520.852 · Estriol.
- 21 CFR 520.863 · Ethylisobutrazine.
- 21 CFR 520.903 · Febantel oral dosage forms.
- 21 CFR 520.903a · a Febantel paste.
- 21 CFR 520.903b · b Febantel suspension.
- 21 CFR 520.903c · c Febantel and praziquantel paste.
- 21 CFR 520.903d · d Febantel tablets.
- 21 CFR 520.905 · Fenbendazole oral dosage forms.
- 21 CFR 520.905a · a Fenbendazole suspension.
- 21 CFR 520.905b · b Fenbendazole granules.
- 21 CFR 520.905c · c Fenbendazole paste.
- 21 CFR 520.905d · d Fenbendazole powder.
- 21 CFR 520.928 · Firocoxib tablets.
- 21 CFR 520.929 · Firocoxib solution.
- 21 CFR 520.930 · Firocoxib paste.
- 21 CFR 520.955 · Florfenicol.
- 21 CFR 520.960 · Flumethasone.
- 21 CFR 520.970 · Flunixin.
- 21 CFR 520.980 · Fluoxetine.
- 21 CFR 520.998 · Fluralaner chewable tablets.
- 21 CFR 520.999 · Fluralaner oral solution.
- 21 CFR 520.1010 · Furosemide.
- 21 CFR 520.1044 · Gentamicin sulfate oral dosage forms.
- 21 CFR 520.1044a · a Gentamicin sulfate oral solution.
- 21 CFR 520.1044b · b Gentamicin sulfate pig pump oral solution.
- 21 CFR 520.1044c · c Gentamicin sulfate powder.
- 21 CFR 520.1060 · Glucose and glycine.
- 21 CFR 520.1084 · Grapiprant.
- 21 CFR 520.1100 · Griseofulvin.
- 21 CFR 520.1120 · Haloxon oral dosage forms.
- 21 CFR 520.1120a · a Haloxon drench.
- 21 CFR 520.1120b · b Haloxon boluses.
- 21 CFR 520.1136 · Ilunocitinib.
- 21 CFR 520.1150 · Imepitoin.
- 21 CFR 520.1156 · Imidacloprid.
- 21 CFR 520.1157 · Iodinated casein.
- 21 CFR 520.1158 · Iodochlorhydroxyquin.
- 21 CFR 520.1189 · Itraconazole.
- 21 CFR 520.1192 · Ivermectin paste.
- 21 CFR 520.1193 · Ivermectin tablets and chewables.
- 21 CFR 520.1194 · Ivermectin meal.
- 21 CFR 520.1195 · Ivermectin liquid.
- 21 CFR 520.1196 · Ivermectin and pyrantel tablets.
- 21 CFR 520.1197 · Ivermectin sustained-release bolus.
- 21 CFR 520.1198 · Ivermectin and praziquantel paste.
- 21 CFR 520.1199 · Ivermectin, pyrantel, and praziquantel tablets.
- 21 CFR 520.1200 · Ivermectin, fenbendazole, and praziquantel tablets.
- 21 CFR 520.1204 · Kanamycin, bismuth subcarbonate, activated attapulgite.
- 21 CFR 520.1242 · Levamisole.
- 21 CFR 520.1242a · a Levamisole powder.
- 21 CFR 520.1242b · b Levamisol boluses or oblets.
- 21 CFR 520.1242c · c Levamisol and piperazine.
- 21 CFR 520.1242d · d Levamisole resinate.
- 21 CFR 520.1242e · e Levamisole hydrochloride effervescent tablets.
- 21 CFR 520.1242f · f Levamisol gel.
- 21 CFR 520.1242g · g Levamisole resinate and famphur paste.
- 21 CFR 520.1248 · Levothyroxine.
- 21 CFR 520.1263 · Lincomycin.
- 21 CFR 520.1263a · a Lincomycin tablets and syrup.
- 21 CFR 520.1263b · b Lincomycin hydrochloride soluble powder.
- 21 CFR 520.1265 · Lincomycin and spectinomycin powder.
- 21 CFR 520.1284 · Liothyronine.
- 21 CFR 520.1286 · Lotilaner.
- 21 CFR 520.1287 · Lotilaner, moxidectin, praziquantel, and pyrantel.
- 21 CFR 520.1288 · Lufenuron tablets.
- 21 CFR 520.1289 · Lufenuron suspension.
- 21 CFR 520.1310 · Marbofloxacin.
- 21 CFR 520.1315 · Maropitant.
- 21 CFR 520.1320 · Mebendazole.
- 21 CFR 520.1326 · Mebendazole and trichlorfon oral dosage forms.
- 21 CFR 520.1326a · a Mebendazole and trichlorfon powder.
- 21 CFR 520.1326b · b Mebendazole and trichlorfon paste.
- 21 CFR 520.1330 · Meclofenamic acid granules.
- 21 CFR 520.1331 · Meclofenamic acid tablets.
- 21 CFR 520.1341 · Megestrol.
- 21 CFR 520.1367 · Meloxicam.
- 21 CFR 520.1375 · Methimazole tablets.
- 21 CFR 520.1376 · Methimazole solution.
- 21 CFR 520.1380 · Methocarbamol.
- 21 CFR 520.1408 · Methylprednisolone.
- 21 CFR 520.1409 · Methylprednisolone and aspirin.
- 21 CFR 520.1422 · Metoserpate hydrochloride.
- 21 CFR 520.1425 · Metronidazole.
- 21 CFR 520.1430 · Mibolerone.
- 21 CFR 520.1441 · Milbemycin.
- 21 CFR 520.1443 · Milbemycin oxime and lufenuron.
- 21 CFR 520.1445 · Milbemycin oxime and praziquantel.
- 21 CFR 520.1447 · Milbemycin oxime, lufenuron, and praziquantel tablets.
- 21 CFR 520.1450 · Morantel tartrate oral dosage forms.
- 21 CFR 520.1450a · a Morantel tartrate bolus.
- 21 CFR 520.1450b · b Morantel tartrate cartridge.
- 21 CFR 520.1450c · c Morantel tartrate sustained-release trilaminate cylinder/sheet.
- 21 CFR 520.1451 · Moxidectin tablets.
- 21 CFR 520.1452 · Moxidectin gel.
- 21 CFR 520.1453 · Moxidectin and praziquantel gel.
- 21 CFR 520.1454 · Moxidectin solution.
- 21 CFR 520.1468 · Naproxen.